| Authors: |
Capener JL; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Schwalm MP; Promega, Madison, WI, USA., Vasta JD; Promega, Madison, WI, USA., Michaud A; Promega, Madison, WI, USA., Teske KA; Promega, Madison, WI, USA., Marsiglia WM; University of Alabama at Birmingham, Birmingham, AL, USA., Huber KVM; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dar AC; Program in Chemical Biology, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Knapp S; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe University, Frankfurt am Main, Germany. knapp@pharmchem.uni-frankfurt.de.; Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Frankfurt am Main, Germany. knapp@pharmchem.uni-frankfurt.de.; German Cancer Consortium (DKTK)/German Cancer Research Center (DKFZ), DTKT Site Frankfurt-Mainz, Heidelberg, Germany. knapp@pharmchem.uni-frankfurt.de., Axtman AD; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. alison.axtman@unc.edu., Robers MB; Promega, Madison, WI, USA. matt.robers@promega.com. |
